Skip to content
10-Q

Quarterly Report

QUANTRX BIOMEDICAL CORPORATION

0001654954-20-005824

← back to feed
Filed
May 20, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 18, 2020 78.7M sh
Total Liabilities Q1 2020 · Mar 31, 2020 $2.28M
Total Liabilities Q1 2020 · Dec 31, 2019 $2.27M
Current Assets Q1 2020 · Mar 31, 2020 $111.98K
Current Assets Q1 2020 · Dec 31, 2019 $137.35K
Total Assets Q1 2020 · Mar 31, 2020 $111.98K
Total Assets Q1 2020 · Dec 31, 2019 $137.35K
Revenue Q1 2020 · Mar 31, 2020 $0
Revenue Q1 2020 · Mar 31, 2019 $0
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$40.1K
Cash And Equivalents Q1 2020 · Mar 31, 2019 $281.92K
Cash And Equivalents Q1 2020 · Dec 31, 2018 $322.02K
Stockholders Equity restated Q1 2020 · Mar 31, 2019 −$1.62M
Stockholders Equity Q1 2020 · Dec 31, 2018 −$1.51M
Sga Expense Q1 2020 · Mar 31, 2019 $22.58K
Net Income Q1 2020 · Mar 31, 2019 −$112.22K
Operating Income Q1 2020 · Mar 31, 2019 −$59K